FDA Inspection 1000028 — Terrebonne General Health System

Terrebonne General Health System — FEI 2370425

The FDA completed an inspection of Terrebonne General Health System on February 10, 2017 in Houma, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 10, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houma, LA (United States)